Vericel Corporation is engaged in the development of patient specific expanded cellular therapies. The company’s autologous cell therapy products include:
Carticel®: Autologous chondrocyte implant designed to treat cartilage defects in the knee
Epicel®: Permanent skin replacement designed to treat deep dermal or full thickness burns that make up thirty percent or more of total body surface area